Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
METEORA CAPITAL, LLC LPBB Launch Two Acquisition Corp. 13G/A 1.08% 3mo
Balyasny Asset Management L.P. RZLT Rezolute, Inc. 13G/A 4.84% 3mo
Atika Capital Management LLC JATT JATT II Acquisition Corp. 13G 5.1% 3mo
Robert Nelsen SANA Sana Biotechnology, Inc. 13G/A 15.4% 3mo
Orbis Investment Management Limited CPAY Corpay, Inc. 13G/A 7.7% 3mo
Vestal Point Capital, LP IMCR Immunocore Holdings plc 13G/A 3.5% 3mo
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. IIIV i3 Verticals, Inc. 13G 5.6% 3mo
Deer X & Co. L.P. HNGE Hinge Health, Inc. 13G/A 3% 3mo
Manulife Investment Management (US) LLC RVSB Riverview Bancorp Inc 13G/A 5.24% 3mo
T. Rowe Price Investment Management, Inc. MSGK MSG Knickerbockers Corp. 13G 5.6% 3mo
1607 Capital Partners, LLC JOF Japan Smaller Capitalization Fund Inc 13G/A 9.61% 3mo
Paradigm Biocapital Advisors LP MAZE Maze Therapeutics, Inc. 13G/A 0% 3mo
Fourthstone LLC CBAN Colony Bankcorp Inc 13G/A 0.79% 3mo
1607 Capital Partners, LLC EVF Eaton Vance Senior Income Trust 13G/A 3.52% 3mo
Ikarian Capital, LLC IRLA IRulya Therapeutics Inc. 13G 9% 3mo
ARMISTICE CAPITAL, LLC INUV Inuvo, Inc. 13G 9.99% 3mo
Sirenia Capital Management LP DSGN Design Therapeutics, Inc. 13G 9.5% 3mo
American Century Investment Management, Inc. PLXS Plexus Corp 13G/A 4.4% 3mo
NOMURA HOLDINGS INC DXLG Destination XL Group, Inc. 13G 6.1% 3mo
Kopernik Global Investors, LLC CNXC Concentrix Corp 13G 5.3% 3mo
Venrock Healthcare Capital Partners III, L.P. ENGN enGene Therapeutics Inc. 13G/A 0% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ VICR Vicor Corp 13G/A 7% 3mo
GREAT POINT PARTNERS LLC PMN ProMIS Neurosciences Inc. 13G/A 7.66% 3mo
Jonathan E. Lim ERAS Erasca, Inc. 13G/A 10.4% 3mo
Fourthstone LLC MNSB MainStreet Bancshares, Inc. 13G/A 0.67% 3mo
Venrock Healthcare Capital Partners III, L.P. VOR Vor Biopharma Inc. 13G/A 9.9% 3mo
TCG Crossover GP I, LLC ABVX Abivax S.A. 13G/A 7% 3mo
Sirenia Capital Management LP ANRO Alto Neuroscience, Inc. 13G/A 6.2% 3mo
RPD Fund Management LLC APPN Appian Corp 13G/A 4.4% 3mo
Alyeska Investment Group, L.P. CPOP Pop Culture Group Co., Ltd 13G 9.99% 3mo
TOMS Capital Investment Management LP BRUN Boost Run Inc. 13G 9.8% 3mo
EAGLE CAPITAL MANAGEMENT LLC WDAY Workday, Inc. 13G 5.63% 3mo
ARMISTICE CAPITAL, LLC ENVB Enveric Biosciences, Inc. 13G 9.99% 3mo
LMR Partners LLP IPFX Inflection Point Acquisition Corp. VI 13G/A 6.7% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC QRED QuasarEdge Acquisition Corp 13G 6.8% 3mo
1607 Capital Partners, LLC TSI Tcw Strategic Income Fund Inc 13G/A 2.84% 3mo
Harraden Circle Investments, LLC RTAC Renatus Tactical Acquisition Corp I 13G/A 6.87% 3mo
Hood River Capital Management LLC KRUS Kura Sushi USA, Inc. 13G/A 0% 3mo
Linden Advisors LP PALO Paloma Acquisition Corp I 13G/A 4.7% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ MDWD MediWound Ltd. 13G/A 5% 3mo
CVI Investments, Inc. CRVO CervoMed Inc. 13G/A 0% 3mo
LMR Partners LLP MDAI Spectral AI, Inc. 13G 6.2% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC GLED GalaxyEdge Acquisition Corp 13G/A 6.8% 3mo
ARK Investment Management LLC BEAM Beam Therapeutics Inc. 13G/A 9.95% 3mo
Karpus Management, Inc. LKSP Lake Superior Acquisition Corp 13G/A 6.4% 3mo
Commodore Capital LP SABS SAB Biotherapeutics, Inc. 13G/A 9.9% 3mo
T. Rowe Price Investment Management, Inc. AUR Aurora Innovation, Inc. 13G/A 18.1% 3mo
Altimeter Capital Management, LP CBRS Cerebras Systems Inc. 13G 6.2% 3mo
Harraden Circle Investments, LLC RMIX Suncrete, Inc. 13G/A 3.8% 3mo
WINDACRE PARTNERSHIP LLC ROP Roper Technologies Inc 13G/A 8.55% 3mo